1. FDA.2018. E11(R1) Addendum: Clinical investigation of medicinal products in the pediatric population.https://www.fda.gov/regulatory-information/search-fda-guidance-documents/e11r1-addendum-clinical-investigation-medicinal-products-pediatric-population. Accessed March 2 2021.
2. EMA.2012. Guideline on pharmaceutical development of medicines for paediatric use.https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-pharmaceutical-development-medicines-paediatric-use_en.pdf. Accessed March 2 2021.
3. Failed pediatric drug development trials;Momper JD;Clin Pharmacol Ther,2015
4. The problems in scaling adult drug doses to children;Johnson TN;Arch Dis Child,2008
5. Recent advances in development and application of physiologically‐based pharmacokinetic (PBPK) models: a transition from academic curiosity to regulatory acceptance;Jamei M;Curr Pharmacol Rep,2016